(Q53023492)

10 May 2018

title

Acetylsalicylic acid inhibition of n-butyl-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats. (English)

1 reference

10 May 2018

1 reference

R Klän

1

1 reference

10 May 2018

H H Knispel

series ordinal

2

1 reference

10 May 2018

T Meier

series ordinal

3

1 reference

10 May 2018

publication date

1 January 1993

1 reference

10 May 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

10 May 2018

volume

119

1 reference

10 May 2018

issue

8

1 reference

10 May 2018

page(s)

482-485

1 reference

10 May 2018

https://scigraph.springernature.com/pub.10.1007/bf01215929

exact match

0 references

cites work

ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma

1 reference

12 December 2020

The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture.

1 reference

12 December 2020

Eicosanoid synthesis by cultured human urothelial cells: potential role in bladder cancer

1 reference

12 December 2020

Prostaglandin H synthase-catalyzed activation of benzidine: a model to assess pharmacologic intervention of the initiation of chemical carcinogenesis.

1 reference

12 December 2020

Prostaglandin hydroperoxidase-mediated 2-amino-4-(5-nitro-2-furyl) [14C]thiazole metabolism and nucleic acid binding

1 reference

12 December 2020

Indomethacin and poly I:C in the inhibition of carcinogen-induced bladder cancer in an experimental animal model.

1 reference

12 December 2020

Combination chemoprevention of rat mammary carcinogenesis by indomethacin and butylated hydroxytoluene

1 reference

12 December 2020

Comparative effects of prostaglandin H synthase-catalyzed binding of two 5-nitrofuran urinary bladder carcinogens.

1 reference

12 December 2020

Bladder cancer epidemiology

1 reference

12 December 2020

Prevention of Recurrent Superficial Bladder Tumors by Oral Etretinate: Preliminary Results of a Randomized, Double Blind Multicenter Trial in Switzerland

1 reference

12 December 2020

Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis

1 reference

12 December 2020

Occupational urothelial cancer

1 reference

12 December 2020

Activation of H-ras oncogene in rat bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine

1 reference

12 December 2020

1 reference

12 December 2020

Concepts in cancer chemoprevention research

1 reference

12 December 2020

Cellular signal transduction and the reversal of malignancy

1 reference

12 December 2020

Enhanced expression of Harvey-ras oncogene in FANFT-induced transitional cell carcinoma

1 reference

12 December 2020

Chemoprevention of bladder cancer

1 reference

12 December 2020

A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

1 reference

12 December 2020

Cigarette smoke extracts inhibit prostacyclin synthesis by the rat urinary bladder

1 reference

12 December 2020

Histogenesis of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats

1 reference

12 December 2020

Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment

1 reference

12 December 2020

Aspirin use and reduced risk of fatal colon cancer

1 reference

12 December 2020

Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01215929

1 reference

10 May 2018

PubMed ID

8509438

1 reference

10 May 2018